Xcovery is a biopharmaceutical company with the aim to improve the lives of cancer patients by discovering and developing innovative medicines to fight advanced tumors. We are working on a pipeline of oncology therapies to target a wide range of malignant diseases. Our lead product, ensartinib (X-396), is a small molecule that inhibits anaplastic lymphoma kinase (ALK). Ensartinib is being investigated for the treatment of ALK positive non-small cell lung cancer. We are currently enrolling patients in our phase 2 and phase 3 clinical studies. Xcovery.com
View Top Employees from XcoveryWebsite | http://www.xcovery.com |
Revenue | $10 million |
Employees | 21 (21 on RocketReach) |
Founded | 2006 |
Address | 11780 US Hwy 1 Suite 202, Palm Beach Gardens, Florida 33408, US |
Phone | (561) 835-9356 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology, Business Services General, Clinical Trials, Oncology, Business Services, Health Care, Discovery Tools (Healthcare), ALK positive lung cancer, Medical, Therapeutics |
Web Rank | 8 Million |
Keywords | Ensartnib, X 396 |
Competitors | Apexigen, Cellphire Therapeutics, Inc., Kereos Inc, Leap Therapeutics, SIBTECH, INC. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Xcovery employee's phone or email?
The Xcovery annual revenue was $10 million in 2024.
Jay Gibbons is the Vice President Oncology of Xcovery.
21 people are employed at Xcovery.
Xcovery is based in Palm Beach Gardens, Florida.
The NAICS codes for Xcovery are [325, 32, 32541, 3254].
The SIC codes for Xcovery are [283, 28].